| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2172040 | Cytotherapy | 2009 | 4 Pages |
Abstract
CD133+ cells are mobilized into the circulation following a single injection of the CXCR4 antagonist plerixafor, without clear evidence for systemic activation of inflammation. This effect may be of importance in cell-based approaches for treating cardiovascular diseases.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Arnon Blum, Richard W. Childs, Aleah Smith, Sushmitha Patibandla, Gloria Zalos, Leigh Samsel, J. Philip McCoy, Gary Calandra, Gyorgy Csako, Richard O. III,